CNS Drugs

, Volume 18, Issue 12, pp 807–825

Tocopherol (Vitamin E) in Alzheimer’s Disease and Other Neurodegenerative Disorders

  • Karen Berman
  • Henry Brodaty
Review Article

DOI: 10.2165/00023210-200418120-00005

Cite this article as:
Berman, K. & Brodaty, H. CNS Drugs (2004) 18: 807. doi:10.2165/00023210-200418120-00005


In this article, we review the evidence that tocopherol (vitamin E) may have a role to play in the prevention and treatment of Alzheimer’s disease and other neurological diseases. The theoretical rationale for the effectiveness of tocopherol as treatment and/or prevention of Alzheimer’s disease is based on its antioxidant properties. Results from animal and in vitro studies provide evidence to support use of tocopherol for prevention and treatment of degenerative neurological diseases. Furthermore, several, but not all, epidemiological, cross-sectional, prospective studies indicate that tocopherol may have protective effects in Alzheimer’s disease, although dietary and supplemental forms of the vitamin may differ in their efficacy. Mixed results have been obtained from clinical trials. Evidence of the use of tocopherol as a protective measure or as therapy in neurological diseases other than Alzheimer’s disease is less compelling. To date, there are no clear-cut answers as to whether tocopherol is worth prescribing, but current clinical practice favours its use in the treatment of Alzheimer’s disease.

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Karen Berman
    • 1
  • Henry Brodaty
    • 1
    • 2
  1. 1.Academic Department for Old Age Psychiatry, Euroa CentrePrince of Wales HospitalRandwickAustralia
  2. 2.School of PsychiatryUniversity of New South WalesSydneyAustralia

Personalised recommendations